Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Más filtros

Bases de datos
Tipo de estudio
Tipo del documento
Intervalo de año de publicación
1.
Bioorg Med Chem Lett ; 22(23): 7189-93, 2012 Dec 01.
Artículo en Inglés | MEDLINE | ID: mdl-23084902

RESUMEN

This paper details exploration of a class of triazole-based cathepsin S inhibitors originally reported by Ellman and co-workers. SAR studies involving modifications across the whole inhibitor provide a perspective on the strengths and weaknesses of this class of inhibitors. In addition, we put the unique characteristics of this class of compounds into perspective with other classes of cathepsin S inhibitors.


Asunto(s)
Amidas/química , Catepsinas/antagonistas & inhibidores , Inhibidores de Proteasas/química , Tiofenos/química , Triazoles/química , Catepsinas/metabolismo , Semivida , Humanos , Microsomas Hepáticos/metabolismo , Inhibidores de Proteasas/síntesis química , Inhibidores de Proteasas/farmacocinética , Unión Proteica , Relación Estructura-Actividad , Tiofenos/síntesis química , Tiofenos/farmacocinética , Triazoles/síntesis química , Triazoles/farmacocinética
2.
Bioorg Med Chem Lett ; 21(7): 2011-6, 2011 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-21354795

RESUMEN

A high-throughput screening campaign has identified 1,4-diazepane compounds which are potent Cannabinoid receptor 2 agonists with excellent selectivity against the Cannabinoid receptor 1. This class of compounds suffered from low metabolic stability. Following various strategies, compounds with a good stability in liver microsomes and rat PK profile have been identified.


Asunto(s)
Azepinas/farmacología , Receptor Cannabinoide CB2/agonistas , Animales , Azepinas/química , Microsomas Hepáticos/metabolismo , Ratas , Ratas Wistar
3.
Lab Chip ; 9(12): 1749-55, 2009 Jun 21.
Artículo en Inglés | MEDLINE | ID: mdl-19495459

RESUMEN

We have developed a miniaturized microfluidic culture system that allows experimentation on individual human embryonic stem cell (hESC) colonies in dynamic (flow applied) or static (without flow) conditions. The system consists of three inlet channels that converge into a cell-culture channel and provides the capability to spatially and temporally deliver specific treatments by using patterned laminar fluid flow to different parts of a single hESC colony. We show that microfluidic culture for 96 h with or without flow results in similar maintenance of hESC self-renewal, the capability to differentiate into three germ cell lineages, and to maintain a normal karyotype, as in standard culture dishes. Localized delivery of a fluorescent nucleic acid dye was achieved with laminar flow, producing staining only in nuclei of exposed cells. Likewise, cells in desired regions of colonies could be removed with enzymatic treatment and collected for analysis. Re-coating the enzyme treated area of the channel with extracellular matrix led to re-growth of hESC colonies into this region. Our study demonstrates the culture of hESCs in a microfluidic device that can deliver specific treatments to desired regions of a single colony. This miniaturized culture system allows in situ treatment and analysis with the ability to obtain cell samples from part of a colony without micromanipulation and to perform sensitive molecular analysis while permitting further growth of the hESC colony.


Asunto(s)
Técnicas de Cultivo de Célula/instrumentación , Células Madre Embrionarias/citología , Microfluídica/métodos , Animales , Diferenciación Celular , Línea Celular , Proliferación Celular , Supervivencia Celular , Enzimas/metabolismo , Matriz Extracelular/metabolismo , Humanos , Indicadores y Reactivos/metabolismo , Ratones , Microfluídica/instrumentación
4.
Bioorg Med Chem Lett ; 19(6): 1588-91, 2009 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-19246196

RESUMEN

Benzamide 1 demonstrated good potency as a selective ITK inhibitor, however the amide moiety was found to be hydrolytically labile in vivo, resulting in low oral exposure and the generation of mutagenic aromatic amine metabolites. Replacing the benzamide with a benzylamine linker not only addressed the toxicity issue, but also improved the cellular and functional potency as well as the drug-like properties. SAR studies around the benzylamines and the identification of 10n and 10o as excellent tools for proof-of-concept studies are described.


Asunto(s)
Bencimidazoles/síntesis química , Química Farmacéutica/métodos , Inhibidores Enzimáticos/síntesis química , Proteínas Tirosina Quinasas/antagonistas & inhibidores , Animales , Bencimidazoles/farmacología , Complejo CD3/biosíntesis , Diseño de Fármacos , Inhibidores Enzimáticos/farmacología , Femenino , Hepatocitos/metabolismo , Humanos , Concentración 50 Inhibidora , Ratones , Ratones Endogámicos BALB C , Ratas , Ratas Sprague-Dawley , Relación Estructura-Actividad
5.
Bioorg Med Chem Lett ; 18(5): 1725-9, 2008 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-18255291

RESUMEN

A high-throughput screening campaign resulted in the discovery of a highly potent dual cannabinoid receptor 1 (CB1) and 2 (CB2) agonist. Following a thorough SAR exploration, a series of selective CB2 full agonists were identified.


Asunto(s)
Receptor Cannabinoide CB2/agonistas , Estructura Molecular , Receptor Cannabinoide CB1/agonistas , Relación Estructura-Actividad
6.
Bioorg Med Chem Lett ; 17(1): 225-30, 2007 Jan 01.
Artículo en Inglés | MEDLINE | ID: mdl-17055721

RESUMEN

An uHTS campaign was performed to identify selective inhibitors of PKC-theta. Initial triaging of the hit set based on selectivity and historical analysis led to the identification of 2,4-diamino-5-nitropyrimidines as potent and selective PKC-theta inhibitors. A homology model and initial SAR is presented demonstrating that a 2-arylalkylamino substituent in conjunction with suitable 4-diamino substituent are essential for achieving selectivity over many kinases. Additional hit to lead profiling is presented on selected compounds.


Asunto(s)
Isoenzimas/antagonistas & inhibidores , Proteína Quinasa C/antagonistas & inhibidores , Inhibidores de Proteínas Quinasas/química , Inhibidores de Proteínas Quinasas/farmacología , Pirimidinas/química , Pirimidinas/farmacología , Linfocitos T CD4-Positivos/efectos de los fármacos , Linfocitos T CD4-Positivos/enzimología , Linfocitos T CD4-Positivos/inmunología , Humanos , Interleucina-2/metabolismo , Modelos Moleculares , Estructura Molecular , Conformación Proteica , Proteína Quinasa C-theta , Relación Estructura-Actividad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA